Previous month Previous day Next day Next month
By Year By Month By Week Today Search Jump to month
Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R21, R33)


Friday, October 16, 2015

This Funding Opportunity Announcement (FOA) invites research grant applications from organizations/institutions that propose the development of novel radioligands for positron emission tomography (PET) or single photon emission computed tomography (SPECT) imaging in human brain, and that incorporate pilot or clinical feasibility evaluation in pre-clinical studies, model development, or clinical studies.

Although this FOA uses the R21 grant mechanism, it runs in parallel with a program announcement of identical scientific scope, PAR-13-158, which uses the R21/R33 Phased Innovation Award grant mechanism.

For more information, please visit: